To determine whether Clb5 is required for the DNA damage response we tested clb5 deletion mutants for sensitivity to MMS. Survival curve analysis showed that these mutants were more sensitive to MMS treatment than the isogenic wild-type strain ( Figure 1a ). We also tested the MMS sensitivity of strains deleted for the CLB5 homologue CLB6. Deletion of CLB6 by itself did not increase MMS sensitivity. clb5 clb6 double mutants, however, showed an MMS sensitivity greater than that of the clb5 mutants, suggesting that Clb5 and Clb6 function together during the DNA damage response. The clb5 clb6 mutants were also hypersensitive to UV and ionizing radiation (data not shown). None of the mutants tested were as sensitive to any treatment as the DNA damage checkpoint mutant mec1 (Figure 1a , and data not shown) [1] . To confirm that the observed increase in MMS sensitivity was indeed due to the absence of Clb5, clb5 clb6 mutants were transformed with a centromeric plasmid containing CLB5.
Results and discussion
To determine whether Clb5 is required for the DNA damage response we tested clb5 deletion mutants for sensitivity to MMS. Survival curve analysis showed that these mutants were more sensitive to MMS treatment than the isogenic wild-type strain ( Figure 1a ). We also tested the MMS sensitivity of strains deleted for the CLB5 homologue CLB6. Deletion of CLB6 by itself did not increase MMS sensitivity. clb5 clb6 double mutants, however, showed an MMS sensitivity greater than that of the clb5 mutants, suggesting that Clb5 and Clb6 function together during the DNA damage response. The clb5 clb6 mutants were also hypersensitive to UV and ionizing radiation (data not shown). None of the mutants tested were as sensitive to any treatment as the DNA damage checkpoint mutant mec1 (Figure 1a , and data not shown) [1] . To confirm that the observed increase in MMS sensitivity was indeed due to the absence of Clb5, clb5 clb6 mutants were transformed with a centromeric plasmid containing CLB5.
The MMS sensitivity of this strain was restored to wildtype levels (Figure 1b) . Together, these results provide evidence that Clb5 and Clb6 are required for the DNA damage response of S. cerevisiae.
Strains lacking CLB5 and CLB6 delay the initiation of DNA replication, resulting in an increase in the proportion of the cell cycle spent with a G1 DNA content [2] . Cells with a 1C DNA content are unable to repair DNA damage using homologous sequences and as a result are more sensitive to DNA damage. It is possible, therefore, that the increase in MMS sensitivity observed for the clb5 clb6 mutants was an artifact of the delayed onset of DNA replication in this strain. To rule out this explanation for the MMS sensitivity of clb5 clb6 mutants, we repeated the assay in diploid strains. clb5/clb5 clb6/clb6 diploid mutants were significantly more sensitive to MMS than the isogenic wild-type strain (Figure 1c ). Like the haploid mutants, the sensitivity of the clb5/clb5 clb6/clb6 mutants could be restored to wild-type levels of MMS sensitivity by introduction of CLB5 on a centromeric plasmid (Figure 1c ). These results indicate that the increase in MMS sensitivity of clb5 and clb5 clb6 mutants is caused by disrupting the DNA damage response pathway, rather than being an artifact of alteration of the timing of DNA replication in these strains.
Increased sensitivity to DNA damage can be caused by either a failure to repair damaged DNA or a failure to arrest in response to DNA damage [3] . To distinguish between these two defects we tested whether we could rescue the DNA-damage-induced lethality of clb5 clb6 mutants with an artificial metaphase arrest [4] . If Clb5 is part of a checkpoint pathway that arrests cells in response to DNA damage, then an artificial arrest should rescue clb5 clb6 mutants exposed to MMS. The MMS sensitivity of clb5 clb6 mutants was significantly decreased when cells were treated with nocodazole to induce spindle damage and activate a metaphase arrest before MMS treatment (Figure 1d ). The increased resistance of clb5 clb6 mutants to MMS when held in nocodazole was not due to the fact that these cells have replicated their DNA because diploid clb5 clb6 mutants are still supersensitive to MMS (Figure 1c ). This result supports a primary function for Clb5 and Clb6 in the DNA damage checkpoint pathway. Viability was not restored to wild-type levels, however. This may reflect a partial role for Clb5 and Clb6 in DNA repair or some sensitivity of this strain to the nocodazole treatment itself.
DNA damage activates a checkpoint pathway that slows progression through S phase [5] . We tested the ability of clb5 clb6 mutants to execute the S-phase checkpoint by monitoring a biochemical marker of the DNA damage response and by FACS measurement of S-phase progression in MMS-treated cells. Phosphorylation of Rad53 is a critical event following DNA damage and is required for the delay of S-phase progression [6] . As shown by shifts in mobility on acrylamide gels, Rad53 was phosphorylated in all strains following MMS treatment (Figure 2a) . Furthermore, FACS analysis showed that both wild-type and clb5 clb6 mutants synchronized in G1 and released into media containing MMS took longer to reach a 2N DNA content than similar strains not exposed to MMS (Figure 2b ). Together, these results provide evidence that, despite their normal function as regulators of DNA replication, Clb5 and Clb6 are not essential for proper execution of the S-phase checkpoint.
We next tested whether clb5 clb6 mutants were able to arrest normally at metaphase following MMS treatment. Cells synchronized at G1 were released into MMS and scored for nuclear division. Whereas wild-type strains arrested as large-budded cells with a short spindle and rarely underwent nuclear division, approximately 50% of the clb5 clb6 mutants underwent nuclear division and anaphase spindle elongation (Figure 3a,b) . Approximately 50% of the nuclear divisions that occurred in clb5 clb6 mutants occurred within the mother or daughter cell, reflecting a spindle-positioning defect previously observed in clb5 clb6 mutants [7, 8] . As might be expected, clb5 clb6 mutants dividing despite the presence of DNA damage displayed unequal nuclear division and aberrant anaphase spindle structures (Figure 3c ). Single clb5 mutants or clb5 clb6 mutants containing CLB5 on a single copy plasmid did not undergo nuclear division in the presence of MMS ( Figure 3a , and data not shown). To determine if the premature nuclear division phenotype accurately represented a defect in sister chromatid separation, we repeated the experiment using sister chromatids marked near the centromere with a GFP tag [9] . In wild-type cells, sister chromatids remained together for up to 4 hours following the release of G1 cells into MMS. In clb5 clb6 mutants exposed to MMS, however, sister chromatids separated within 90 minutes following release from MMS (Figure 3d ). These data indicate that Clb5 and Clb6 act together during exposure to DNA damage to maintain sister chromatid cohesion during metaphase arrest induced by the DNA damage checkpoint.
Arrest at metaphase following DNA damage requires accumulation of the anaphase inhibitor Pds1 [10] [11] [12] . We tested the possibility that clb5 clb6 mutants could not arrest at metaphase because they do not accumulate Pds1. Pds1 levels were not significantly different in wild-type The S-phase checkpoint is activated in clb5∆ clb6∆ mutants. (a) Rad53 is phosphorylated following MMS treatment. Mid-log cultures of each strain were treated with 0.05% MMS for 30 min. Immediately following MMS treatment, cells were frozen and whole cell extracts prepared. Western analysis was performed using anti-Rad53 antibody. (b) Extended delay of S-phase progression in clb5∆ clb6∆ mutants exposed to MMS. Cultures of wild-type (WT) or clb5∆ clb6∆ mutants were arrested in G1 using 100 ng/ml α-factor for 2.5 h. Cells were washed 3X in fresh media and then released into either media or media + 0.05% MMS. At each time point cells were fixed in 70% EtOH and prepared for FACS analysis to determine DNA content. All data are representative of at least three separate experiments. 
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and clb5 clb6 strains exposed to MMS (Figure 4a ). Pds1 accumulated with the same kinetics following release from G1 and remained present at similar levels in both strains throughout the experiment. This suggests that in clb5 clb6 mutants Pds1 is unable to inhibit sister chromatid separation. To test this hypothesis and to exclude the possibility that there were small changes in Pds1 levels, we tested the effect of non-degradable Pds1 expression in clb5 clb6 mutants (Figure 4b ). Wild-type and clb5 clb6 mutants were arrested at G1, induced to express non-degradable GFP-tagged Pds1, and then released from the α-factor arrest. The expression of this form of Pds1 was monitored by following GFP-associated immunofluorescence. Wild-type cells expressing nondegradable GFP-Pds1 arrested with unseparated nuclei, consistent with previous reports [10] (Figure 4b ). In contrast, clb5 clb6 cells expressing non-degradable GFP-Pds1 underwent nuclear division with kinetics similar to those of a non-expressing wild-type strain. (Figure 4b ). Together, these results provide evidence that Pds1 cannot inhibit nuclear division in the absence of the S-phase cyclins Clb5 and Clb6.
Pds1 prevents sister chromatid separation by binding Esp1, preventing Esp1 activation of Scc1 degradation and sister chromatid separation [13, 14] . Like Pds1, Scc1 levels were not significantly different in wild-type versus clb5 clb6 mutants synchronized in G1 and released into MMS (data not shown). To determine if the premature anaphase observed in clb5 clb6 mutants resulted from a failure of Scc1 to maintain sister chromatid cohesion, we utilized a non-degradable form of Scc1 and scored cells for metaphase arrest. As reported by others, expression of non-degradable Scc1 arrested wild-type cells at metaphase ( [15] , and Figure 4c ). Expression of non-degradable Scc1 in clb5 clb6 mutants caused a metaphase arrest similar to that seen for wild-type cells. Thus, Scc1 can inhibit nuclear division in the absence of Clb5 and Clb6. This suggests that Clb5 and Clb6 act on, downstream of, or in a parallel pathway to Pds1, and upstream of Scc1 to induce a stable metaphase arrest.
Two pathways are thought to induce complete metaphase arrest following DNA damage [16] . In one pathway, Pds1 binds Esp1 and prevents its ability to activate cleavage of the sister chromatid 'glue' Scc1 [14] . The other pathway includes RAD53, DUN1, and CDC5 and inhibits sister chromatid separation by an unknown mechanism [16, 17] . How these two pathways work together to regulate metaphase arrest following DNA damage is unclear, but they may converge to regulate SCC1 cleavage. For example, rad53 mutants separate sister chromatids despite DNA damage, but do not do so in the presence of non-degradable Pds1, suggesting that Rad53 inhibition of sister chromatid separation may be dependent on Pds1 functions [17] . Though the precise position of Clb5 and Clb6 in this regulatory network is unclear, one testable model is that these two cyclins function jointly with Pds1 to regulate Esp1 activation of Scc1 degradation during a prolonged metaphase arrest. Whether they do this independently of the Rad53 pathway remains to be determined.
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Figure 3
Clb5 and Clb6 are required for metaphase arrest following MMS treatment. (a) Inappropriate nuclear division in clb5∆ clb6∆ mutants exposed to MMS. Left, wild-type and clb5∆ clb6∆ mutants were arrested in G1 and released into MMS as described in Figure 2b . At each time point cells were fixed in 70% ethanol, treated with 0.1 mg/ml RNaseA for 60 min, stained with 16 µg/ml propidium iodide, and scored for budding and nuclear division. Circles, wild type; triangles, clb5∆; squares, clb5∆ clb6. Clb5 and Clb6 are required for Pds1 to inhibit the metaphase-to-anaphase transition.
(a) Pds1 accumulates normally in clb5∆ clb6∆ mutants following MMS exposure. Strains were synchronized in G1 and released into MMS (t = 0) as described in Figure 2b . Pds1 levels were detected using anti-Pds1 antibody. Loading was determined using anti-tubulin antibody. WT, wild type. (b) Nuclear division occurs in clb5∆ clb6∆ mutants despite the presence of non-degradable Pds1. Wild-type and clb5∆ clb6∆ mutants were transformed with a centromeric plasmid containing a galactose-inducible, non-degradable form of Pds1 tagged with GFP. Mid-log cultures in YP + 2% raffinose were arrested for 3.5 h with 100 ng/ml α-factor. During the last hour of arrest galactose was added to 2% to induce Pds1 expression. The α-factor was then washed out and cells were released (t = 0) into YP + galactose to continue Pds1 expression for another hour, after which dextrose was added to inhibit expression. Samples were removed every 30 min, fixed in 3.7% formaldehyde for 3 min, and stained with DAPI. Cells that showed strong GFP signal (> 30% of cells) were scored for budding and nuclear division. Left, nuclear division in the clb5∆ clb6∆ mutant despite the presence of non-degradable Pds1. Circles, wild-type + non-degradable Pds1; triangles, clb5∆ clb6∆ + non-degradable Pds1; squares, wild-type + vector. Right, example of nuclear division in a GFP-positive clb5∆ clb6∆ strain. The sample was taken 120 min after release from α-factor. (c) Non-destructible Scc1 inhibits nuclear division in wild-type and clb5∆ clb6∆ mutants. Procedure was identical to that described for (b) except that nuclear morphology was scored using propidium iodide as in Figure 3a . 
